HERNEXEOS DIN 02571730
Health Canada record
| Active ingredient(s) | ZONGERTINIB 60 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | L01EH04 ZONGERTINIB |
| Original market date | |
| Current status date | 24-Sep-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
Boehringer Ingelheim (Canada) Ltd Ltee — licence 100187, currently licensed, last inspection rating C (2025-03-03).
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 38344 | 2026-09-24 | New Drug Submission (NDS) |